Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.

Saved in:
Bibliographic Details
Title: Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.
Authors: Irsara, Christian1 (AUTHOR), Egger, Alexander E.1 (AUTHOR), Prokop, Wolfgang1 (AUTHOR), Nairz, Manfred2 (AUTHOR), Loacker, Lorin1 (AUTHOR), Sahanic, Sabina2 (AUTHOR), Pizzini, Alex2 (AUTHOR), Sonnweber, Thomas2 (AUTHOR), Mayer, Wolfgang3 (AUTHOR), Schennach, Harald3 (AUTHOR), Loeffler-Ragg, Judith2 (AUTHOR), Bellmann-Weiler, Rosa2 (AUTHOR), Tancevski, Ivan2 (AUTHOR), Weiss, Günter2 (AUTHOR), Anliker, Markus1 (AUTHOR), Griesmacher, Andrea1 (AUTHOR), Hoermann, Gregor1,4 (AUTHOR) gregor.hoermann@tirol-kliniken.at
Source: Clinical Chemistry & Laboratory Medicine. 2021, Vol. 59 Issue 6, p1143-1154. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14346621
DOI:10.1515/cclm-2020-1758